Posttraumatic stress disorder from early childhood to late adolescence: a resilience-oriented approach to prevention, diagnosis, and clinical management Authors: Hala Kerbage, Eric Bui, Alexis Revet, Hélène Denis, Diane Purper-Ouakil, Julie Rolling Published: 2026 ABSTRACT AbstractPosttraumatic stress disorder (PTSD) in children and adolescents remains underrecognized despite its significant developmental, relational, and public health impact. This narrative review synthesizes evidence on the prevention, diagnosis, and management of PTSD from early childhood through late adolescence, emphasizing a resilience-oriented and multisystemic framework. Developmentally informed assessment is essential to capture age-specific symptom patterns and to distinguish PTSD from complex PTSD, increasingly observed after chronic interpersonal trauma. Trauma-focused psychotherapies—particularly trauma-focused cognitive behavioral therapy (TF-CBT)—are the gold standard, with eye movement desensitization and reprocessing (EMDR) and narrative exposure therapy (KidNET) as effective alternatives. In the early post-trauma phase, single-session debriefing is discouraged, whereas selective multisession interventions such as the Child and Family Traumatic Stress Intervention (CFTSI) reduce acute distress and strengthen caregiver support. No pharmacological treatment is approved for pediatric PTSD; psychotherapy remains first-line, with selective serotonin reuptake inhibitors considered only for severe, persistent, or comorbid cases after shared decision-making. Recovery depends not only on symptom reduction but also on restoring safety, attachment, and agency through coordinated interventions involving family, peers, schools, and communities. Integrating resilience-building and social-support strategies across clinical, educational, and policy levels is key to sustainable recovery and long-term developmental health.Keywords: Posttraumatic stress disorder, Children and adolescents, Trauma-focused psychotherapy, Family and social support, Resilience promotion Introduction Posttraumatic stress disorder (PTSD) in children and adolescents remains frequently underdiagnosed despite its substantial developmental, relational, and public health impact [1, 2]. Lifetime PTSD prevalence among adolescents ranges from 4 to 8% in community samples [3–5] and is markedly higher among refugees, war-exposed youth, and survivors of sexual abuse [6, 7]. Early trauma exposure increases vulnerability to a wide range of psychiatric and physical outcomes—depression, suicidal behaviours, substance use, and cardiovascular disease [8–13]. Yet recognition in pediatric practice remains low, and many affected youth do not receive evidence-based trauma-focused interventions [14]. Current diagnostic frameworks—largely derived from adult criteria—may overlook developmental variations in symptom expression. Overlap with depression, ADHD, anxiety disorders, and autism spectrum disorder complicates detection, and cultural factors shape how children express distress. Interpersonal trauma in childhood (abuse, neglect, exposure to violence) disrupts emotion regulation, stress reactivity, and neurodevelopment, producing a symptom spectrum that may exceed the classic PTSD clusters of re-experiencing, avoidance, negative cognitions/affect, and hyperarousal [15]. ICD-11’s distinction between PTSD and Complex PTSD (CPTSD) may better capture the presentations of youth exposed to chronic interpersonal trauma [16], while proposals such as Developmental Trauma Disorder highlight attachment dysregulation and developmental impairments not fully represented in DSM-5 [14, 15]. Recent global events—including the COVID-19 pandemic, armed conflicts, migration crises, and increased attention to early adversity—have heightened awareness of trauma-related needs among young people. There is growing consensus that prevention and treatment must extend beyond symptom reduction to strengthen protective factors such as supportive relationships, adaptive coping skills, and community resources [17]. A resilience-oriented framework acknowledges heterogeneous trajectories and the potential for adaptive functioning even after severe adversity. This narrative review synthesizes evidence on prevention, diagnosis, and management of PTSD from early childhood to late adolescence, emphasizing a developmentally informed, culturally sensitive, and resilience-oriented perspective. It is not intended as an exhaustive systematic review but focuses on clinically relevant domains: Developmental considerations and diagnostic challenges; Developmental considerations and diagnostic challenges; Current evidence and gaps in psychotherapeutic and pharmacological treatments; Current evidence and gaps in psychotherapeutic and pharmacological treatments; The role of caregiver, peer, school, and community support in promoting recovery. The role of caregiver, peer, school, and community support in promoting recovery. We conclude with a developmentally informed treatment algorithm to guide decision-making across symptom profiles and comorbidities. Search strategy This article is a structured narrative review. Literature was identified through targeted searches in PubMed and PsycINFO, complemented by manual searches of reference lists and key guidelines (e.g., NICE, ISTSS, WHO). Priority was given to systematic reviews, meta-analyses, randomized controlled trials, and high-quality cohort studies published primarily between 2010 and 2025. Search terms included combinations of “posttraumatic stress disorder,” “children,” “adolescents,” “complex PTSD,” “early intervention,” “trauma-focused therapy,” “resilience,” and “pharmacotherapy.” Selection was guided by clinical relevance, methodological rigor, and alignment with the developmental and resilience-oriented focus of the review. Our approach is consistent with previously published practitioner-oriented narrative reviews in the field (e.g., Smith et al. [14]). Developmental and diagnostic considerations Symptom expression across developmental stages While PTSD in youth shares core disruptions in fear processing and emotion regulation, its presentation varies substantially with cognitive, emotional, and social development. From infancy onward, neural circuits for threat detection are functional but regulatory systems remain immature, making young children particularly vulnerable to trauma. Preschool-aged children often express distress behaviourally rather than verbally. Trauma may manifest through repetitive or symbolic play, regression (bedwetting, clinginess), irritability, tantrums, or separation anxiety [18]. Nightmares are common but often vague or non-specific [19]. Avoidance appears as withdrawal from activities or caregivers linked to the trauma, while hyperarousal may present as restlessness or exaggerated startle responses. To address underrecognition, DSM-5 introduced a preschool-specific PTSD subtype [20]. In middle childhood (6–12 years), expanding language and cognitive abilities allow more coherent accounts of traumatic experiences, though somatic complaints (headaches, abdominal pain) frequently dominate clinical presentations [19, 21]. Emerging guilt worries about consequences, academic decline, concentration difficulties, and school avoidance are typical. Children may continue trauma-related play while engaging in more intentional avoidance of reminders. Sleep disturbances often persist, and nightmares become more specific. In adolescence, symptoms become more self-reported, especially intrusions, hypervigilance, and physiological reactivity. However, developmental tasks—identity formation, autonomy, and peer alignment—shape clinical expression. Network analyses suggest intrusions and hypervigilance become increasingly central and interconnected, contributing to persistence [21]. Untreated PTSD may fuel risk-taking, substance use, interpersonal conflict, and self-harm, particularly in adolescents with cumulative trauma or comorbid depression [22, 23]. Suicidal ideation and behaviours are more frequent, driven by hyperarousal, shame, hopelessness, and withdrawal [22–24]. Sleep problems are highly prevalent and represent both a mediator and a treatment target [24]. Comorbidities (depression, anxiety, substance use) complicate both detection and management. These developmental trajectories highlight the need for age-sensitive screening: behavioural and dissociative cues in younger children; intrusive symptoms, hypervigilance, and suicidal risk in adolescents; and careful exploration of impairment across home, school, and peer environments. Diagnostic frameworks: introducing complex PTSD DSM-5 defines PTSD through exposure to trauma and four symptom clusters: intrusions, avoidance, negative alterations in cognition/mood, and hyperarousal [20]. ICD-11 streamlines this into three clusters—re-experiencing, avoidance, and persistent sense of threat—and introduces Complex PTSD (CPTSD), characterized by PTSD symptoms plus disturbances in self-organization (DSO): affect dysregulation, negative self-concept, and interpersonal difficulties [16]. Dissociation, including depersonalisation and derealisation, may complicate presentations across ages [25, 26], while ICD-11’s dimensional and cross-cultural sensitivity offers advantages in diverse populations [27, 28]. Table 1 summarizes diagnostic differences. Table 1Diagnostic Criteria for PTSD in DSM-5, ICD-11, and Complex PTSD in ICD-11FeatureDSM-5 PTSD (APA, 2013)ICD-11 PTSD (WHO, 2017)ICD-11 Complex PTSD (WHO, 2017)Trauma exposureExposure to actual or threatened death, serious injury, or sexual violence (direct, witnessed, indirect, or repeated exposure)Similar definition of traumatic exposureSame as PTSD, typically prolonged or repeated interpersonal trauma (eg, abuse, captivity, chronic violence)Symptom clusters4 clusters: (1) Intrusion (eg, flashbacks, nightmares); (2) Avoidance; (3) Negative alterations in cognition and mood; (4) Alterations in arousal and reactivity3 clusters: (1) Re-experiencing in the present; (2) Avoidance; (3) Persistent sense of current threat (hypervigilance, exaggerated startle)Includes all 3 PTSD clusters plus disturbances in self-organization: (1) Affective dysregulation; (2) Negative self-concept; (3) Interpersonal difficultiesDevelopmental considerationsPreschool subtype for children ≤ 6 years with modified criteria; otherwise, adult-centricNo specific child subtype: streamlined criteria to enhance developmental and cross-cultural sensitivityParticularly relevant for children/adolescents exposed to chronic developmental traumaDissociationDissociative subtype: depersonalization and/or derealizationNot core, may co-occurMay co-occur, but focus is on identity and relational disruptionsDurationSymptoms > 1 month after traumaSymptoms persist several weeks (usually > 1 month)Same as PTSD; chronicity emphasized in context of prolonged traumaFunctional impairmentRequiredRequiredRequiredConceptual frameworkCategorical, symptom-based, broader criteriaDimensional, streamlined, fewer symptoms, improved cross-cultural validityDimensional extension of PTSD; recognizes impact of prolonged trauma on emotion regulation, self, and relationships Diagnostic Criteria for PTSD in DSM-5, ICD-11, and Complex PTSD in ICD-11 Children and adolescents exposed to chronic interpersonal trauma (abuse, neglect, domestic violence, trafficking, war) often display emotional and relational disturbances beyond classic PTSD criteria. Affective dysregulation may manifest through explosive anger, rapid mood shifts, or numbing; negative self-concept through shame, guilt, or worthlessness; interpersonal difficulties through mistrust or dependency [29]. These symptoms reflect adaptations to compromised caregiving environments and disrupted attachment systems. Among displaced or refugee children, trauma is compounded by loss, displacement, and ongoing stressors, reinforcing the need for diagnostic approaches integrating developmental and contextual factors [30]. The Memory and Identity Theory of CPTSD posits that high-risk traumas particularly disrupt identity development, fostering negative self-perceptions and fragmented memories [31]. Individual vulnerabilities—e.g., social support, coping capacity, pre-existing psychopathology—shape these trajectories [31]. Some trauma-exposed youth may not form accessible traumatic memories, while others may maintain a coherent self despite severe trauma. These variations underscore that PTSD and CPTSD represent possible pathways, influenced by developmental stage, trauma type, chronicity, and social context [32]. Recognizing CPTSD has direct implications for assessment and care. Brief symptom checklists may detect core PTSD features, but comprehensive evaluations must explore affect regulation, identity processes, and relational patterns. ICS-11–aligned instruments such as the International Trauma Questionnaire (ITQ) support nuanced case formulation and are validated in adolescent samples [33]. Epidemiology and risk factors Global prevalence and high-risk populations Trauma exposure is widespread in adolescents, with over half reporting at least one event [34–36]. PTSD point prevalence ranges from < 1–5% in general populations but rises substantially among trauma-exposed youth. Systematic reviews suggest 15–35% of trauma-exposed children develop PTSD, with higher rates following interpersonal trauma and among girls [7, 37–39]. Refugee and conflict-affected minors show rates of 20–40% [6, 40, 41], and earthquake-related PTSD reaches around 26% [42]. Longitudinal data show prevalence declining from 21% at one month to ~ 11% at one year, with little spontaneous recovery thereafter [43]. However, in war-related trauma, prevalence may increase over time, highlighting cumulative and delayed impacts [6]. Limited studies suggest CPTSD may be as frequent or more frequent than PTSD in high-risk children and adults [44–47], though some cases may overlap with affective comorbidity or borderline traits [48]. CPTSD is particularly associated with early, interpersonal, prolonged trauma [46–49]. Risk factors for PTSD PTSD arises through interacting individual, social, and situational determinants. Adolescents—particularly over 14—appear more vulnerable than younger children [39, 50], possibly due to greater cognitive insight into trauma consequences or underrecognition in younger children. Females show consistently higher risk [51–55], linked to both exposure patterns (e.g., sexual abuse) and emotion-oriented coping [55]. Cumulative trauma is a major predictor: interpersonal trauma yields significantly higher prevalence (25%) than non-interpersonal trauma (10%) [37]. Other risk factors include lower IQ, socioeconomic disadvantage, pre- and post-trauma stressors, pre-existing mental health problems, bereavement, trauma severity, low social support, thought suppression, maladaptive appraisals, and poor family functioning [7, 37, 55–58]. Parental mental health plays a consistent role in shaping youth outcomes [59–61]. Peritraumatic emotions (fear, helplessness) and maladaptive post-traumatic cognitive processes (negative appraisals, intrusive memories, avoidance, rumination) predict chronicity [55–58]. Violent bereavement is particularly potent [38, 55, 56]. Biological vulnerabilities (HPA axis, inflammation, genetics) interact with psychosocial factors but remain heterogeneous [62]. Conversely, social support is one of the strongest protective factors, underscoring the multisystemic nature of recovery [56, 63, 64]. Overall, risk factors rarely act independently but cluster interactively—e.g., parental distress weakening social support, bereavement intensifying maladaptive cognitions. These patterns highlight the need for prevention approaches targeting children, caregivers, and social environments simultaneously. Beyond psychosocial risk factors, emerging developmental neuroscience provides further insight into how trauma becomes biologically embedded across development. Research led by McLaughlin and colleagues has demonstrated that early adversity can alter the maturation of neural circuits involved in emotion regulation, threat processing, and social cognition, particularly within amygdala–prefrontal networks [10, 15]. Distinctions between experiences of threat and deprivation have been shown to differentially affect cognitive and emotional development, suggesting that trauma exposure may shape neurodevelopment in domain-specific ways [15]. These findings provide a biological foundation for understanding how trauma may impact affect regulation, interpersonal functioning, and behavioral adaptation, and underscore the importance of developmentally sensitive and transdiagnostic treatment approaches. Importantly, emerging evidence also suggests that neurodevelopment remains plastic, highlighting opportunities for intervention and recovery even after significant adversity [15]. Treatment interventions for PTSD in children and adolescents Psychotherapeutic approaches The past three decades have seen major advances in the development and evaluation of psychological interventions for PTSD in children and adolescents. From early adaptations of adult trauma therapies to developmentally tailored approaches, the evidence now strongly supports the use of trauma-focused psychotherapies as first-line treatments in this population [14, 65]. Nonetheless, treatment availability in the community remains limited, especially for younger children, displaced populations, and those living in low-resource or humanitarian settings [66, 67]. Interventions are increasingly being adapted for school or digital delivery, offering potential for scalability. Importantly, adaptations for younger populations often place greater emphasis on building a strong therapeutic alliance, incorporating conjoint sessions with parents, teaching stabilization techniques to improve affect and behavioural regulation, and using visual tools or creative forms of expression to enhance communication [68, 69]. Below, we review the major psychotherapies along with emerging school-based and digital programs. Trauma-focused cognitive behavioral approaches Well-established trauma-focused cognitive-behavioral therapies represent the first-line psychological treatment for pediatric PTSD [65]. In this review, we use the term trauma-focused cognitive behavioral therapies (TF-CBTs) as an umbrella framework encompassing a range of structured interventions grounded in shared cognitive and exposure-based mechanisms. These approaches are typically based on the cognitive model proposed by Ehlers and Clark, which attributes therapeutic effectiveness in adults with PTSD to the modification of maladaptive appraisals linked to the trauma [70] as well as the reduction of safety-seeking behaviours—particularly avoidance [71, 72]. Core therapeutic components commonly include psychoeducation to normalize trauma reactions; cognitive restructuring to challenge maladaptive assumptions and reactions; emotional processing to support meaning-making; relaxation strategies; coping skills training such as problem-solving, safety planning, and anxiety management; and both imaginal and in vivo exposure exercises to reduce distress associated with trauma reminders [73, 74]. Combined, these techniques aim to promote adaptive processing of traumatic memories and reduce symptom persistence. Adaptations for pediatric populations frequently involve caregiver participation, either integrated into sessions or offered as adjunct interventions [75]. Caregiver involvement may enhance outcomes by strengthening parents’ ability to identify trauma symptoms and to support children in managing distress and related behavioural problems [76]. Within this broader framework, several manualized and empirically supported protocols have been developed. Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), as originally developed by Cohen and colleagues [77] is the most extensively studied and is widely recommended as the gold-standard treatment for pediatric PTSD [65, 78–80]. Multiple randomized controlled trials and meta-analyses have demonstrated its superiority to waitlist and active controls, with moderate-to-large effect sizes and sustained benefits over time [81–85]. Follow-up data suggest that treatment gains are generally durable: many children maintain symptom remission six to twelve months post-treatment, with spontaneous relapse being relatively uncommon [14, 75]. However, sustained effects in highly unstable contexts (e.g., displacement, ongoing violence) are less certain [66]. Other structured approaches include prolonged exposure-based interventions, such as Prolonged Exposure for Adolescents (PE-A), which has demonstrated efficacy in reducing PTSD symptoms in trauma-exposed adolescents compared with supportive counselling [86]. Similarly, cognitive therapy for PTSD has shown effectiveness in youth exposed to multiple traumatic stressors in real-world clinical settings, including in pragmatic trials involving highly comorbid populations [87]. These approaches share core mechanisms with TF-CBT while differing in structure, emphasis, and delivery format. Importantly, these interventions have also been adapted for younger children. TF-CBT-based approaches have been modified for preschool-aged children through simplified language, play-based exposure, developmentally tailored emotional processing, and strong caregiver involvement. Emerging evidence suggests that even very young children can benefit from such interventions, although the evidence base remains more limited compared to older age groups [88]. Eye movement desensitization and reprocessing (EMDR) Although trauma-focused cognitive behavioural therapy (TF-CBT) remains the treatment with the strongest evidence base for paediatric PTSD, support for EMDR is steadily growing. EMDR combines exposure and cognitive restructuring with bilateral stimulation, typically via guided eye movements. During sessions, the child recalls traumatic memories while following the therapist’s fingers. The proposed mechanisms involve dual-attention stimulation, which may reduce the vividness and emotional intensity of traumatic memories and facilitate adaptive reprocessing [89]. These features can be advantageous for children who struggle to provide a detailed trauma narrative. A systematic review and meta-analysis of studies published between 2010 and 2020 found no significant differences between EMDR and TF-CBT in reducing PTSD symptoms, though EMDR showed stronger effects for comorbid depression and anxiety [90]. A larger meta-analysis of 30 studies reported that TF-CBT was marginally more effective overall, while confirming that both approaches produced clinically meaningful symptom reductions and showed similar long-term maintenance of gains. Youth with subclinical PTSD tended to benefit more than those with full diagnoses, and comorbidity predicted larger improvements [91]. A recent network meta-analysis synthesizing data from 70 RCTs (n = 5528) found that both TF-CBT and EMDR outperformed passive controls. TF-CBT produced the largest short-term reductions in PTSD severity and maintained benefits over 6–24 months, although fewer long-term data were available for EMDR [92]. Overall, EMDR represents an effective alternative, particularly for children reluctant or unable to engage in detailed trauma processing. Reflecting this evidence, the National Institute for Health and Care Excellence recommends EMDR when young people do not engage in or respond to TF-CBT [79]. However, the limited number of high-quality paediatric RCTs and scarce long-term follow-up underscore the need for further trials to clarify EMDR’s place in the hierarchy of evidence-based treatments [93]. Recent developments in EMDR protocols include the so-called “blind-to-therapist” (BTT) approach, in which the client processes traumatic material without disclosing its specific content to the therapist. Although primarily studied in adult populations [90] this adaptation highlights the potential importance of non-verbal trauma processing. Such an approach may hold relevance for children and adolescents who struggle to articulate traumatic experiences, including younger children or youth affected by shame, dissociation, or cultural barriers to disclosure. However, empirical evidence for the application of BTT protocols in pediatric PTSD remains limited, and further research is needed to clarify its clinical utility in this population. Narrative exposure therapy (NET/KidNET) Narrative Exposure Therapy (NET) and its child-focused adaptation, KidNET, were specifically developed for populations exposed to chronic and repeated trauma, such as refugee or war-affected children. The therapeutic rationale is to reconstruct a chronological life narrative, weaving traumatic memories into a coherent autobiographical story. This process contextualizes trauma within the child’s broader life, reduces fragmentation, and fosters a sense of continuity and agency [94, 95]. Its structured storytelling format also aligns well with cultural traditions of oral history, supporting cross-cultural acceptability. NET shares core mechanisms with other exposure-based approaches, particularly prolonged exposure, and is sometimes conceptualized within the broader family of trauma-focused cognitive-behavioral interventions. However, it is distinguished by its focus on reconstructing a coherent life narrative, which may be particularly relevant for individuals exposed to repeated or chronic trauma [94]. Evidence for KidNET in children and adolescents is promising but mixed. A meta-analysis of RCTs and controlled trials found that post-treatment effects were small to medium and non-significant, possibly due to underpowered analyses and the use of active control groups such as relaxation training or treatment-as-usual, which may have reduced the pooled effect sizes [95]. However, follow-up data showed medium to large effects, suggesting that KidNET’s impact may strengthen over time as children integrate traumatic experiences into their autobiographical memory [95]. Consistent with this, six-month follow-up results in refugee and displaced youth demonstrated medium effect sizes [67]. While the evidence base is considerably stronger for NET in adults, KidNET shows emerging efficacy for paediatric populations. Nevertheless, study quality is variable, with heterogeneity, small samples, and limited long-term data constraining firm conclusions. KidNET appears particularly promising for refugee and chronically trauma-exposed youth, although the current evidence base remains smaller and more heterogeneous than for TF-CBT, with variability in study quality and effect sizes. Group and school-based interventions School- and group-based interventions are widely used where access to specialist mental health care is limited, especially in humanitarian and low-resource settings. They are scalable, require minimal specialist training, and can be delivered to large groups in classrooms or community settings [96]. Programs may be targeted (for children with elevated PTSD symptoms) or universal (for all children). Most draw on CBT principles—psychoeducation, coping skills, and exposure—and emphasize peer support, normalization of trauma responses, and reduced stigma and accessibility barriers [97–99]. The exposure components overlap with those used in structured exposure-based interventions such as Prolonged Exposure for Adolescents (PE-A), although school-based programs generally involve adapted and lower-intensity delivery formats. A meta-analysis of 42 RCTs (N = 5998) found that group-based interventions were effective across diverse trauma-exposed populations, including youth affected by war, disaster, and abuse [66]. Group programs showed medium effect sizes for reducing PTSD symptoms compared with controls, with benefits maintained at follow-up and extending to comorbid depression. Effectiveness did not differ significantly by income level, program format (universal vs. targeted), or caregiver involvement, underscoring their adaptability. CBT-based programs showed particularly robust effects. A systematic review of 27 RCTs in humanitarian contexts (16 targeted, n = 2356; 11 universal, n = 3378) similarly found significant reductions in PTSD symptoms for both program types compared with passive controls [85]. Targeted interventions also reduced comorbid depressive symptoms and maintained gains at follow-up, while universal programs demonstrated preventive effects. Outcomes did not vary by country income, trauma type, or delivery by professionals versus lay facilitators, supporting the feasibility of task-sharing in low-resource settings. Together, these findings indicate that school- and group-based programs—universal or targeted—are effective in reducing PTSD symptoms in children and adolescents, including in highly resource-scarce and crisis-affected settings. Digital interventions While TF-CBT is effective, it remains resource-intensive and limited by the availability of trained clinicians. Digital adaptations of CBT-based interventions therefore represent a promising strategy to expand access to trauma-focused care for children and adolescents. These programs are generally well accepted by young people and have shown benefits for depression and anxiety [100, 101], though evidence for posttraumatic stress symptoms (PTSS) remains limited. Available digital tools vary widely in content and delivery [102], most drawing on modular online CBT formats, sometimes incorporating gamified smartphone applications [103]. A recent meta-analysis of five controlled trials [104–108] reported modest within-group reductions in PTSS but negligible between-group differences compared with controls, underscoring the early and still preliminary nature of this field. Early interventions Despite extensive literature on PTSD treatments, evidence for interventions delivered within the first three months post-trauma remains limited. Although many children recover spontaneously after a single event [43], the acute post-trauma phase often involves distressing sub-diagnostic symptoms—intrusions, hyperarousal, irritability—that cause suffering and may disrupt development [109]. Given the high prevalence of trauma exposure, many youth remain at risk for persistent PTSD or related disorders. This early period represents a critical window to reduce acute distress, mobilize parental and social support, and address risk factors shaping long-term outcomes. Preventive strategies have shifted from universal interventions for all trauma-exposed youth to selective, symptom-targeted approaches. Single-session psychological debriefing has proven ineffective and potentially harmful [110], leading Cochrane and NICE to advise against its routine use [79, 111]. In contrast, psychological first aid (PFA) and brief psychoeducational or supportive interventions—focused on safety, stabilization, coping, and connectedness without detailed emotional processing—are recommended by international guidelines [78–80]. More promising are multisession, selective early interventions for children already presenting posttraumatic stress symptoms. The Child and Family Traumatic Stress Intervention (CFTSI) is the best-validated model. Developed for youth aged 7–17, it comprises five to eight sessions to strengthen parental support, enhance communication, and improve coping and behavioural regulation [112]. CFTSI has shown significant reductions in child PTSD diagnoses at three months [112] and in large multisite trials [109]. A meta-analysis also found decreases in parental symptoms [113], and digital adaptations have reduced PTSD symptoms in both children and parents under chronic trauma exposure [114]. These findings underscore that early mobilization of family resources is central, as these protective systems directly shape the child’s recovery. Psychological therapies for CPTSD Most studies guiding current therapeutic recommendations for PTSD have focused on children and adolescents exposed to a single traumatic event. This leaves important gaps regarding the effectiveness of therapies for children exposed to prolonged trauma, particularly those with complex PTSD (C-PTSD). Although recognized in ICD-11, C-PTSD is not included as a distinct DSM-5 entity, where its manifestations are addressed through specifiers or comorbidities, creating uncertainty about optimal trauma-focused treatments and preferred approaches. In pediatric populations, no standardized, validated treatment for C-PTSD currently exists [115]. The International Society for Traumatic Stress Studies (ISTSS) nevertheless provides consensus on functional domains to target—PTSD symptoms and disturbances in self-organization—highlighting the need for individualized, adaptive approaches, whether integrative or sequential [78]. Several therapeutic models have been developed or adapted for C-PTSD in adults, sharing core components and generally following a phased structure. These psychotherapies begin with psychoeducation, stabilization, and skill development in emotional regulation, interpersonal resources, and self-esteem, before progressing to trauma processing and, ultimately, integration and consolidation [116, 117]. This stepwise structure addresses the severe symptom profiles seen in C-PTSD, where affective dysregulation, negative self-concept, and relational difficulties may hinder direct engagement in trauma-focused work. Ongoing efforts aim to adapt and validate these approaches for children and adolescents. Three main categories can be distinguished: Multimodal therapies developed for populations exposed to repeated traumatic events These include STAIR (Skills Training in Affective and Interpersonal Regulation), which focuses on building emotional and interpersonal regulation skills. Its efficacy is reported as moderate in adults [116, 117], with improved emotion regulation and reduced post-traumatic symptoms in a group of adolescent girls aged 12–17 years [118]. STAIR is considered primarily a stabilization program, with trauma work usually added afterward. ITCT (Integrative Treatment of Complex Trauma) for Adolescent [119] integrates CBT, attachment theory, and developmental approaches within a highly individualized framework. Although early findings are encouraging [120], evidence remains limited and further RCTs are needed. Multimodal therapies developed for populations exposed to repeated traumatic events These include STAIR (Skills Training in Affective and Interpersonal Regulation), which focuses on building emotional and interpersonal regulation skills. Its efficacy is reported as moderate in adults [116, 117], with improved emotion regulation and reduced post-traumatic symptoms in a group of adolescent girls aged 12–17 years [118]. STAIR is considered primarily a stabilization program, with trauma work usually added afterward. ITCT (Integrative Treatment of Complex Trauma) for Adolescent [119] integrates CBT, attachment theory, and developmental approaches within a highly individualized framework. Although early findings are encouraging [120], evidence remains limited and further RCTs are needed. Adaptations of validated PTSD therapies for C-PTSD Trauma-Focused CBT (TF-CBT), prolonged exposure, and EMDR have been adapted for complex trauma. TF-CBT, initially designed for sexually abused youth [121] has shown significant benefits for PTSD and comorbidities. A naturalistic study comparing youth with PTSD and C-PTSD found greater reductions in PTSD, C-PTSD, and disturbances in self-organization among C-PTSD patients, with comparable dropout rates [122]. Given its phased structure (skills building, trauma processing, cognitive restructuring, interpersonal work, and parental involvement), TF-CBT appears particularly well-suited to C-PTSD. Sachser et al. [123] confirmed its efficacy in adolescents, with effects on self-organization and interpersonal difficulties, though more modest on emotional regulation. EMDR, validated for pediatric PTSD [124] has specific adaptations for C-PTSD emphasizing preparation (safety, resource building, tolerance of affect), progressive trauma selection, and tailored bilateral stimulation. While meta-analyses support its use in child PTSD, few studies focus on C-PTSD; some suggest reductions in PTSD and related symptoms [125]. The MARS trial [126] is currently comparing a phased approach (STAIR-A followed by EMDR) to immediate trauma-focused EMDR in adolescents exposed to repeated abuse and domestic violence, aiming to clarify optimal therapeutic sequencing. Adaptations of validated PTSD therapies for C-PTSD Trauma-Focused CBT (TF-CBT), prolonged exposure, and EMDR have been adapted for complex trauma. TF-CBT, initially designed for sexually abused youth [121] has shown significant benefits for PTSD and comorbidities. A naturalistic study comparing youth with PTSD and C-PTSD found greater reductions in PTSD, C-PTSD, and disturbances in self-organization among C-PTSD patients, with comparable dropout rates [122]. Given its phased structure (skills building, trauma processing, cognitive restructuring, interpersonal work, and parental involvement), TF-CBT appears particularly well-suited to C-PTSD. Sachser et al. [123] confirmed its efficacy in adolescents, with effects on self-organization and interpersonal difficulties, though more modest on emotional regulation. EMDR, validated for pediatric PTSD [124] has specific adaptations for C-PTSD emphasizing preparation (safety, resource building, tolerance of affect), progressive trauma selection, and tailored bilateral stimulation. While meta-analyses support its use in child PTSD, few studies focus on C-PTSD; some suggest reductions in PTSD and related symptoms [125]. The MARS trial [126] is currently comparing a phased approach (STAIR-A followed by EMDR) to immediate trauma-focused EMDR in adolescents exposed to repeated abuse and domestic violence, aiming to clarify optimal therapeutic sequencing. Adaptations from therapies originally developed for personality disorders or high-risk behaviors Dialectical Behavior Therapy (DBT), initially developed for suicidality and borderline personality disorder combines individual and multifamily therapy, skills training, and team supervision. The adolescent version (DBT-A) has shown good acceptability and effectiveness in youth with severe emotional dysregulation [127]. A C-PTSD-specific version (DBT-PTSD) demonstrated superiority over cognitive therapy in adults with childhood abuse-related PTSD and borderline traits, with better remission, recovery, and lower dropout [128]. These findings highlight the relevance of targeting emotional dysregulation and interpersonal difficulties in C-PTSD. Early applications of DBT adaptations in adolescents with complex trauma are promising, though results remain inconsistent across studies [129–131]. Adaptations from therapies originally developed for personality disorders or high-risk behaviors Dialectical Behavior Therapy (DBT), initially developed for suicidality and borderline personality disorder combines individual and multifamily therapy, skills training, and team supervision. The adolescent version (DBT-A) has shown good acceptability and effectiveness in youth with severe emotional dysregulation [127]. A C-PTSD-specific version (DBT-PTSD) demonstrated superiority over cognitive therapy in adults with childhood abuse-related PTSD and borderline traits, with better remission, recovery, and lower dropout [128]. These findings highlight the relevance of targeting emotional dysregulation and interpersonal difficulties in C-PTSD. Early applications of DBT adaptations in adolescents with complex trauma are promising, though results remain inconsistent across studies [129–131]. Taken together, these results suggest that evidence-based interventions such as TF-CBT may be more effective for CPTSD youth than previously assumed, while novel phase-based approaches like DBT-PTSD highlight the potential benefit of targeting emotion dysregulation and relational difficulties. Nevertheless, the overall evidence base remains limited, echoing the caution raised by the ISTSS [132] and highlighting the need for larger, controlled studies to refine treatment recommendations. Pharmacological interventions Only a handful of randomized controlled trials (RCTs) have evaluated pharmacological treatments for pediatric PTSD. In a small trial (N = 24) of sexually abused youth aged 10–17 years, Cohen et al. [133] found no added benefit of combining sertraline with trauma-focused CBT (TF-CBT) compared with TF-CBT plus placebo. Similarly, a larger RCT (N = 131) reported no significant difference between sertraline and placebo in reducing PTSD symptoms [134]. More recently, a large retrospective cohort study using the U.S. TriNetX database (n = 83,252) compared antidepressant prescribing patterns in youth with PTSD alone versus those with comorbid ADHD [135]. Youth with PTSD-ADHD were significantly more likely to receive SSRIs, but treatment persistence was lower, with higher rates of switching, underscoring questions about efficacy and tolerability in this subgroup. Overall, robust evidence for pharmacological treatment in children and adolescents is lacking, and no medication is currently approved for pediatric PTSD. In adults, sertraline and paroxetine are the only agents approved by both the FDA and EMA, with fluoxetine and venlafaxine also supported by guideline-based efficacy data [136]. In younger populations, sertraline has the most favorable safety profile—based on data from other pediatric indications such as depression and anxiety—but evidence for its benefit in PTSD is insufficient. Consequently, pharmacotherapy should not be considered first-line; trauma-focused psychotherapies remain the recommended approach. When significant comorbidities or severe, persistent symptoms warrant pharmacologic support, an SSRI—preferably sertraline—may be considered only after careful discussion with the child and parents regarding the limited evidence base, potential risks, and need for close monitoring. Beyond SSRIs, exploratory reports from small open-label series and case studies have suggested possible benefit of antipsychotics (e.g., risperidone, quetiapine), mood stabilizers (e.g., carbamazepine), and anti-adrenergic agents (e.g., clonidine, propranolol), though evidence remains limited by weak designs and small samples. Guanfacine, an α2A-adrenergic receptor agonist that modulates prefrontal cortical noradrenergic activity, has been investigated more systematically given the role of adrenergic hyperarousal in re-experiencing, vigilance, and sleep disturbances. In an open-label pilot study of 19 youth (6–18 years), guanfacine extended release over eight weeks was associated with significant reductions in re-experiencing and hyperarousal, alongside improved sleep and comorbid anxiety, with good tolerability [137]. While preliminary, these findings point to guanfacine as a promising adjunct, warranting RCTs. Symptom-targeted interventions have also been tested, particularly for sleep disturbances, which represent a highly impairing symptom in paediatric PTSD. A retrospective chart review of 42 inpatients (ages 4–18) with PTSD-associated nightmares found prazosin to be well tolerated, with more than half showing improvement [138]. Similarly, the ongoing MelatoSOM-Kids-PTSD trial is evaluating prolonged-release melatonin (PedPRM) for PTSD-related sleep disturbances, leveraging prior evidence in autism spectrum disorders [139]. Novel agents have also been explored. D-cycloserine, tested as an adjunct to TF-CBT in 57 youth (7–18 years), did not enhance outcomes compared to placebo [140]. Ketamine, a noncompetitive NMDA receptor antagonist, has shown rapid and robust reductions in PTSD symptoms in adults [141], fueling interest in glutamatergic pathways as therapeutic targets. However, concerns regarding durability, safety, and repeated dosing remain, and no pediatric trials have been conducted [142]. Similarly, MDMA-assisted psychotherapy (MDMA-AP) has demonstrated efficacy in adults with severe PTSD [143] and is being considered for adolescents given challenges with avoidance and engagement in traditional therapies [144]. MDMA may reduce hyperarousal and avoidance, strengthen therapeutic alliance, and promote extinction learning [145–148] but safety, misuse potential, and ethical concerns preclude use in minors until rigorous trials are conducted [149–151]. Ifenprodil, a GluN2B-selective NMDA antagonist with additional adrenergic and sigma-1 actions, showed short-term benefit on hyperarousal and dissociation in a pilot RCT of 10 adolescents but effects were not sustained, highlighting the need for larger trials [152]. Preventive pharmacological approaches Preventive pharmacological approaches in the peritraumatic phase have produced mixed results. In one RCT, sertraline showed moderate efficacy in reducing parent-reported—but not child-reported—posttraumatic symptoms in burn-injured children [153]. Morphine was also associated with decreased arousal symptoms in similar samples, possibly mediated by pain relief rather than direct effects on traumatic stress [154, 155]. In contrast, propranolol failed to prevent PTSD across two RCTs and a retrospective study [156–158]. Advances in understanding fear-learning circuits suggest potential for neuromodulatory interventions such as non-invasive brain stimulation (NIBS), which may modulate amygdala–mPFC–hippocampal activity implicated in abnormal fear consolidation [159, 160]. Similarly, evidence of HPA-axis dysregulation and inflammatory involvement in PTSD points to hydrocortisone as the compound with the strongest preventive evidence in adults [161]. However, this approach has not yet been studied in children or adolescents, highlighting the need for dedicated trials examining the safety and developmental implications of early pharmacological modulation of stress responses. Toward a resilience-oriented model of care for PTSD Mounting evidence from developmental science, psychiatry, and epigenetics underscores that resilience is best understood as a dynamic, multisystemic process shaped by individual, familial, social, cultural, and ecological factors across the lifespan. Individuals are more likely to adapt positively to trauma when embedded in networks that include supportive caregivers, stable environments, cohesive peer groups, and cultural narratives affirming identity and belonging. Bronfenbrenner and Morris [162] describe human development as unfolding within nested ecological systems—microsystems (family, school), mesosystems (connections between these), exosystems (community institutions), macrosystems (sociopolitical context), and chronosystems (historical time and life transitions). From this perspective, resilience emerges through ongoing reciprocal interactions across these layers, aligning with Ungar’s multidimensional model [163] and Masten’s multisystem framework [164]. These approaches shift attention away from internal strengths or therapeutic compliance toward an ecologically grounded understanding of adaptation, recognizing that developmental stage, context, and resource availability critically shape resilience [165]. Rather than a fixed individual trait, resilience is increasingly conceptualized as a dynamic process. It emerges from ongoing transactions between individuals and their environments, evolving across developmental stages and contexts. Protective and promotive factors operate at multiple levels. At the individual level, secure attachment, emotion regulation, problem-solving skills, and distress tolerance foster adaptive functioning. At the family level, caregiver responsiveness, parenting quality, household stability, and income security provide buffering effects. At the community level, safe environments, schools, peer support, social cohesion, and cultural continuity strengthen belonging and competence, while at the societal level, access to services, equitable policies, and structural protections further contribute to resilience [166, 167]. It is the cumulative and interactive effects of these factors, rather than any single influence, that determine trajectories of recovery and adaptation. Cultural and contextual factors also shape resilience processes. In sub-Saharan Africa, for example, young people often rely on female caregivers, reflecting both demographic patterns and caregiving traditions [166]. In post-conflict settings, cultural rituals and collective survival narratives have been shown to strengthen communal resilience, while in urban environments, infrastructure, green spaces, and community safety significantly influence children’s well-being [165]. Translating these insights into clinical care requires combining trauma-focused therapies with interventions that deliberately strengthen protective systems. Parenting support programs enhance caregiver responsiveness and buffer stress reactivity, promoting secure attachment and emotional regulation [164–168]. School-based reintegration initiatives restore educational continuity and peer connectedness, mitigating PTSD trajectories, while community- and peer-based interventions reduce stigma, foster belonging, and expand access to supportive relationships [163–169]. Clinical assessments can integrate resilience measures such as the Child and Youth Resilience Measure [170] to monitor protective processes alongside symptom change, making resilience-building an explicit therapeutic target [164]. Interventions delivered early after trauma exposure, or among chronically exposed populations, can prevent maladaptive trajectories by reinforcing caregiving stability, peer networks, and community resources [163–166]. In these contexts, resilience-oriented care sustains developmental progress despite ongoing adversity by continually strengthening relational, educational, and cultural supports [165]. Taken together, this developmental-ecological approach reframes intervention goals: beyond alleviating PTSD symptoms, it aims to restore developmental pathways and foster long-term well-being by embedding protective factors into multilevel interventions and creating sustainable pathways to recovery, agency, and thriving across the lifespan. Proposed treatment algorithm The effective psychiatric management of children and adolescents exposed to trauma requires a flexible and layered approach that responds to developmental needs, comorbidities, symptom profiles, and the ways families themselves perceive trauma and recovery. Interventions should begin as early as possible, even before specialized mental health services are involved. First-line professionals such as general practitioners, school nurses, or social workers often represent the first point of contact after trauma exposure. Their role in providing trauma-informed support—offering safety, validating the child’s reactions, delivering simple psychoeducation to parents, and identifying those who may require rapid referral—is essential. Such early engagement helps reduce distress, mitigate stigma, and prevent secondary adversities while fostering a sense of agency in families by involving them actively in decisions from the outset. Treatment planning then proceeds according to the child’s developmental stage, symptom severity, and comorbidities. Younger children often manifest trauma responses through agitation, irritability, or behavioral changes rather than verbal narratives. For them, stabilizing routines, offering safe environments, and supporting caregivers in responding consistently to emotional needs are key early steps. School-aged children and adolescents, who can engage more directly in therapeutic processes, may benefit from trauma-focused cognitive behavioral therapies or narrative approaches that combine psychoeducation, coping-skills training, and gradual exposure to trauma reminders. Throughout this process, fostering agency—helping children and parents make informed choices about coping strategies, school reintegration, and the pace of therapy—supports both adherence and empowerment. Comorbidities shape priorities: for example, acute suicidality or major depression may necessitate crisis stabilization before trauma-focused interventions, while neurodevelopmental disorders such as ADHD may require tailored behavioral strategies and caregiver collaboration to maintain engagement. In addition, maintaining factors—such as PTSD-related sleep disturbances—should be identified explicitly and addressed as key therapeutic targets. Psychotherapy remains the first-line treatment for pediatric PTSD, with pharmacotherapy considered when symptoms are severe, persistent, or when comorbid anxiety or mood disorders interfere with psychological work. Even in such cases, medication should complement rather than replace psychotherapeutic and psychosocial interventions. Social interventions—including school reintegration support, parenting guidance, and peer support groups—further strengthen recovery and reduce isolation. To address the large treatment gap worldwide, specialized therapies must also be scalable, whether through digital platforms, group-based delivery, or task-sharing models where trained non-specialists deliver structured, evidence-based components under supervision. For example, in Kenya, the Shamiri Institute, has developed a community-based mental health model in which trained non-psychologists (near-peers) deliver culturally adapted psychosocial programs in schools to improve well-being and reduce distress-related symptoms [171]. This ensures access beyond specialized urban centers and into underserved or rural communities while allowing families to choose from different formats according to their needs and circumstances. A resilience-promoting mindset should inform both assessment and intervention. Beyond measuring symptoms alone, evaluations can explore social support, coping resources, and emotion-regulation skills, guiding interventions that build strengths alongside symptom reduction. Such a perspective helps families and children see recovery not only as the absence of distress but also as the active restoration of competence, confidence, and connectedness, with agency as a cornerstone—children and parents become participants rather than passive recipients in the healing process. Cultural adaptation further requires attention to how families themselves interpret trauma and resilience. Parents and children may hold diverse beliefs about what causes psychological suffering, how healing occurs, and what role professional care should play. Some may view distress through moral, spiritual, or familial lenses rather than psychological ones, shaping expectations about what help is acceptable or effective. Engaging families in conversations about their representations and perceived needs helps address misconceptions—such as fears that talking about the trauma will worsen symptoms—and builds trust while preserving the core principles of evidence-based care [172, 173]. Recognizing these perspectives also allows clinicians to support families in reclaiming a sense of control over their recovery journey, even amid uncertainty. Overall, a stepped, developmentally informed, and culturally attuned algorithm that integrates early trauma-informed responses, multimodal interventions, scalable delivery methods, a resilience-oriented mindset, and a focus on agency offers the best chance of reducing the burden of pediatric PTSD and improving long-term recovery trajectories. Box 1 details the components of the proposed algorithm. Box 1Algorithm for assessment and treatment of PTSD in children and adolescents: resilience-oriented, family and social-systems approach)1. Initial Assessment and Safety Screen for immediate risks (suicidality, ongoing abuse, psychosis, substance use) Provide psychological first aid (PFA) principles: ensure safety, stabilize distress, and restore basic functioning Offer parental guidance and coordination with school/community supports Identify developmental stage, trauma type, and protective resources (family cohesion, peer relationships, school engagement)2. Early Post-Trauma Phase (< 3 months): Reduce acute distress and strengthen protective systems Avoid single-session psychological debriefing (ineffective/potentially harmful) Provide psychoeducation and supportive counseling for parents/caregivers Implement selective early interventions for symptomatic youth (e.g., CFTSI, 5–8 sessions) Reinforce family and peer connectedness, daily routines, and community participation3. Established PTSD (> 3 months or persistent symptoms): First-line: Trauma-Focused Psychotherapy Trauma-focused CBT approaches with caregiver involvement (including manualized TF-CBT and prolonged exposure-based interventions) EMDR as effective alternative, especially when verbal processing is limited KidNET/NET may be considered in refugee, war-exposed, or repeated trauma contexts, particularly where narrative approaches are culturally acceptable, although evidence remains less robust than for TF-CBT Combine with group/school-based or digital CBT interventions (often based on core trauma-focused components, including exposure) to improve access Throughout therapy: strengthen social support networks (family, peers, teachers)4. Complex PTSD / Severe Dysregulation Phased approach: Stabilization & skills (e.g., STAIR, DBT-informed, parenting skills) Trauma processing (TF-CBT, EMDR/NET) Integration & reconnection (identity, relationships, meaning-making) Address comorbidities (depression, ADHD) and build resilience through supportive environments5. Pharmacological Interventions (Adjunct Only) No medication approved for pediatric PTSD Trauma-focused psychotherapy remains first-line Consider SSRI (preferably sertraline) only for severe, persistent, or comorbid conditions, after discussion of risks/benefits with family and close monitoring Manage sleep/nightmares behaviorally; consider prazosin only with caution6. Long-Term Recovery and Resilience Promotion Maintain family, peer, and school collaboration Encourage social re-engagement, empowerment, and mastery activities Monitor symptom course and protective factors every 4–6 weeks; adjust intensity Integrate resilience-building interventions: social connectedness, self-efficacy, emotion regulation, and meaning reconstruction Facilitate access to community-based and culturally adapted resourcesCore Principle: Recovery from childhood trauma is not achieved solely through symptom reduction but through restoring safety, relationships, and agency. Interventions that mobilize family and social supports and strengthen resilience processes at individual and systemic levels have the greatest potential for sustainable healing Algorithm for assessment and treatment of PTSD in children and adolescents: resilience-oriented, family and social-systems approach) Screen for immediate risks (suicidality, ongoing abuse, psychosis, substance use) Provide psychological first aid (PFA) principles: ensure safety, stabilize distress, and restore basic functioning Offer parental guidance and coordination with school/community supports Identify developmental stage, trauma type, and protective resources (family cohesion, peer relationships, school engagement) Avoid single-session psychological debriefing (ineffective/potentially harmful) Provide psychoeducation and supportive counseling for parents/caregivers Implement selective early interventions for symptomatic youth (e.g., CFTSI, 5–8 sessions) Reinforce family and peer connectedness, daily routines, and community participation Trauma-focused CBT approaches with caregiver involvement (including manualized TF-CBT and prolonged exposure-based interventions) EMDR as effective alternative, especially when verbal processing is limited KidNET/NET may be considered in refugee, war-exposed, or repeated trauma contexts, particularly where narrative approaches are culturally acceptable, although evidence remains less robust than for TF-CBT Combine with group/school-based or digital CBT interventions (often based on core trauma-focused components, including exposure) to improve access Throughout therapy: strengthen social support networks (family, peers, teachers) Stabilization & skills (e.g., STAIR, DBT-informed, parenting skills) Trauma processing (TF-CBT, EMDR/NET) Integration & reconnection (identity, relationships, meaning-making) No medication approved for pediatric PTSD Trauma-focused psychotherapy remains first-line Consider SSRI (preferably sertraline) only for severe, persistent, or comorbid conditions, after discussion of risks/benefits with family and close monitoring Manage sleep/nightmares behaviorally; consider prazosin only with caution Maintain family, peer, and school collaboration Encourage social re-engagement, empowerment, and mastery activities Monitor symptom course and protective factors every 4–6 weeks; adjust intensity Integrate resilience-building interventions: social connectedness, self-efficacy, emotion regulation, and meaning reconstruction Facilitate access to community-based and culturally adapted resources Core Principle: Recovery from childhood trauma is not achieved solely through symptom reduction but through restoring safety, relationships, and agency. Interventions that mobilize family and social supports and strengthen resilience processes at individual and systemic levels have the greatest potential for sustainable healing Although the present algorithm is structured around established diagnostic frameworks (DSM-5 and ICD-11), its multidimensional and culturally sensitive design is broadly compatible with transdiagnostic approaches such as the NIMH Research Domain Criteria (RDoC) [174]. The RDoC framework conceptualizes psychopathology across core domains of functioning—including negative and positive valence systems, cognitive systems, social processes, and arousal/regulatory systems—rather than relying solely on categorical diagnoses. In the context of complex trauma, where emotional dysregulation, cognitive distortions, interpersonal difficulties, and arousal disturbances frequently co-occur across diagnostic boundaries, an RDoC-informed lens may enrich assessment and case formulation. Integrating domain-based clinical questioning into trauma-focused care may further support whole-person, developmentally sensitive treatment planning. Conclusion PTSD from early childhood to late adolescence is common, heterogeneous, and frequently under-recognized. Developmental stage, trauma type (especially chronic interpersonal trauma), family context, and sociocultural environment shape symptom expression, comorbidity, and prognosis. First-line care is psychological: TF-CBT has the strongest evidence across ages; EMDR is an effective alternative (especially when narrative work is difficult) and KidNET is promising for chronically exposed/refugee youth. School- and group-based programs can reduce symptoms at scale, while digital CBT adaptations remain early-stage. In the first three months post-trauma, universal single-session “debriefing” is not recommended; instead, brief supportive responses (e.g., PFA, parent psychoeducation) and selective, multisession early interventions such as CFTSI can reduce acute symptoms and mobilize protective family factors. Pharmacotherapy has no approved pediatric indication and pediatric RCTs are few; medication is not first-line. If, after shared decision-making, medication is considered for severe, persistent symptoms or disabling comorbidity, SSRIs—preferably sertraline given pediatric safety data from other indications—should be used cautiously with close monitoring. Preventive pharmacologics show mixed findings; hydrocortisone has the most adult evidence but no pediatric trials to date. A resilience-oriented, multisystem model is essential. Such an approach combines evidence-based trauma therapies with interventions that strengthen caregiver, school, peer, and community supports. Together, these layers offer the best path to restore developmental trajectories and reduce long-term burden. Key gaps include robust trials for CPTSD in youth, long-term and implementation studies (including task-sharing), and pediatric prevention/adjunct pharmacology. Author contributions H.K. conceived the review, designed the overall structure, and conducted the literature search. H.K. E.B. and J.R. synthesized the evidence and wrote the main manuscript text. A.R., H.D., D.P-O., and J.R. contributed to the literature review, provided clinical and methodological input, and critically revised the manuscript for important intellectual content. All authors reviewed and approved the final version of the manuscript. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate Not applicable. Consent for publication Not applicable. Competing interests The authors report no conflict of interest. This work has not received any funding. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.